These emerging therapies , Tirzepatide , represent a groundbreaking advancement in addressing obesity and conceivably other ailments . These drugs are grouped as GLP-1 receptor agonists , signifying they to replicate the body's GLP-1 hormone , stimulating metabolic production and suppressing hung